The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts
Open accessAbstract
Over the last 17 years, there has been a remarkable increase in scientific research concerning chronic traumatic encephalopathy (CTE). Since the publication of NINDS–NIBIB criteria for the neuropathological diagnosis of CTE in 2016, and diagnostic refinements in 2021, hundreds of contact sport athletes and others have been diagnosed at postmortem examination with CTE. CTE has been reported in amateur and professional athletes, including a bull rider, boxers, wrestlers, and American, Canadian, and Australian rules football, rugby union, rugby league, soccer, and ice hockey players. The pathology of CTE is unique, characterized by a pathognomonic lesion consisting of a perivascular accumulation of neuronal phosphorylated tau (p-tau) variably alongside astrocytic aggregates at the depths of the cortical sulci, and a distinctive molecular structural configuration of p-tau fibrils that is unlike the changes observed with aging, Alzheimer’s disease, or any other tauopathy. Computational 3-D and finite element models predict the perivascular and sulcal location of p-tau pathology as these brain regions undergo the greatest mechanical deformation during head impact injury. Presently, CTE can be definitively diagnosed only by postmortem neuropathological examination; the corresponding clinical condition is known as traumatic encephalopathy syndrome (TES). Over 97% of CTE cases published have been reported in individuals with known exposure to repetitive head impacts (RHI), including concussions and nonconcussive impacts, most often experienced through participation in contact sports. While some suggest there is uncertainty whether a causal relationship exists between RHI and CTE, the preponderance of the evidence suggests a high likelihood of a causal relationship, a conclusion that is strengthened by the absence of any evidence for plausible alternative hypotheses. There is a robust dose–response relationship between CTE and years of American football play, a relationship that remains consistent even when rigorously accounting for selection bias. Furthermore, a recent study suggests that selection bias underestimates the observed risk. Here, we present the advances in the neuropathological diagnosis of CTE culminating with the development of the NINDS–NIBIB criteria, the multiple international studies that have used these criteria to report CTE in hundreds of contact sports players and others, and the evidence for a robust dose–response relationship between RHI and CTE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 The pathognomonic lesion of CTE and the staging schemes of pathological severity (adapted with permission from [83]). Representative images of p-tau pathology at Low and High chronic traumatic encephalopathy (CTE) pathological stage using the abbreviated staging scheme recommended by the second NINDS/NIBIB consensus panel (low–high) [11] and the McKee staging scheme (I–IV) [4, 79]. Low CTE is characterized by p-tau pathology restricted to focal cortical lesions. High CTE shows widespread p-tau pathology in the medial temporal lobe structures and diencephalon in addition to focal cortical lesions. McKee Stage I CTE is characterized by one or two isolated CTE lesions at the depths of the cortical sulci. In stage II, three or more cortical CTE lesions are found. In stage III CTE, there are multiple CTE lesions and diffuse NFTs in the medial temporal lobe. In stage IV CTE, CTE lesions and NFTs are widely distributed throughout the cerebral cortex, diencephalon, and brainstem. Top row: hemispheric 50-µm tissue sections immunostained with CP-13, directed against phosphoserine 202 of tau (courtesy of Peter Davies, Ph.D., Feinstein Institute for Medical Research; 1:200); positive p-tau immunostaining appears dark brown. Bottom row: 10-µm paraffin-embedded tissue sections immunostained for phosphorylated tau (AT8) (Pierce Endogen). Positive p-tau immunostaining appears dark red, hematoxylin counterstain. I A 26-year-old former college football player with stage I CTE (Low). Two perivascular p-tau CTE lesions are evident at the sulcal depths of the frontal cortex; there is no neurofibrillary degeneration in the medial temporal lobe. II A 49-year-old former NFL player with stage II CTE (Low). There are multiple perivascular p-tau CTE lesions at depths of sulci of the frontal cortex; there is no neurofibrillary degeneration in the amygdala or entorhinal cortex. III A 53-year-old former NFL player with stage III CTE (High). There are multiple CTE lesions in the frontal cortex and insula; there is diffuse neurofibrillary degeneration of hippocampus and entorhinal cortex (asterisk). IV A 62-year-old former NFL player with stage IV CTE (High). There are multiple CTE lesions in the cerebral cortex with widespread neurofibrillary degeneration. There is also extensive neurofibrillary degeneration of the amygdala and entorhinal cortex (asterisk). a Pathognomonic CTE lesion in stage I CTE. AT8 immunopositive neurofibrillary tangles, dot-like and threadlike neurites encircle a small blood vessel. b Pathognomonic CTE lesion in stage II CTE. A cluster of AT8 immunopositive neurofibrillary tangles and dense dot-like neurites surround several small blood vessels, c pathognomonic CTE lesion in stage III CTE. A large collection of AT8 immunopositive neurofibrillary tangles and dense dot-like neurites enclose several small blood vessels. With increasing age, AT8 immunoreactive astrocytes are increasingly evident within the pathognomonic lesion (open triangle). d Pathognomonic CTE lesion in stage IV CTE. A large accumulation of AT8 immunopositive neurofibrillary tangles, most of them ghost tangles, encompass several small blood vessels. With increasing age, AT8 immunoreactive astrocytes are increasingly prominent (open triangles) and there may be evidence of neuronal loss. a–d All magnification × 200. P-tau phosphorylated tau, CTE chronic traumatic encephalopathy, NFL National Football League](https://figures.cochat.ai/paper-figures/7dd2755e8f23446e8cd37ae42f32f79e/chronic-traumatic-encephalopathy-cte-criteria-for-neuropathological-diagnosis-figure-1.jpg)


![Fig. 4 The evolution of 3R/4R tau and astrocytic involvement in CTE pathology (adapted with permission from [21] and [17]). a Quantitative measurement of the relative ratios of 4R/3R p-tau present in the dorsolateral frontal cortex at the depth of the cortical sulcus across the stages of CTE. Values over 0 contain more 4R tau while values under 0 contain more 3R tau. Although 4R predominates at all stages of disease, there is relatively more 3R tau with increasing CTE stage. In cells containing 4R tau in CTE stage I and II, 95.8% ± 10.2% and 96.1% ± 4.7% were neurons, respectively. For CTE stage III and IV, 65.6% ± 28.7% and 69.7% ± 26.0% of cells containing 4R were neurons, respectively [21]. b Linear regression analysis of the 4R/3R ratio compared to the AT8 p-tau staining density in the dorsolateral frontal cortex. Data is log transformed. Each dot represents one case. As AT8 pathology accumulates, there is a decreasing ratio of 4R/3R p-tau [21]. c Quantitative measurement of the relative percentages of neurons and astrocytes that contain p-tau in the pathognomonic CTE lesion. Neurons contain both 3R and 4R while astrocytes only contain 4R ptau. Neurons were the primary cell type associated with the CTE lesion. Further ANCOVA analysis demonstrated that CTE stage was not significantly correlated with the percentage of 4R astrocytes around the lesion when including age at death as a covariate in the model (p = 0.031), suggesting age is a stronger driver of p-tau astrocytes than CTE stage. d Relative percentages of neurons and astrocytes in pathognomonic lesion that contain 4R tau stratified by decade of age at death. Data is presented as mean ± SD. There is a significant increase in astrocytic 4R p-tau with age at death, most prominent over age 60. e, f Percentage of neuronal, subpial astrocytic, and parenchymal astrocytic p-tau densities separated by CTE stage (e), and decade of age (f) further demonstrating the presence of p-tau positive astrocytes in the parenchyma are driven more by age than disease stage. Subpial astrocytes are also driven by age, first appearing at age > 40 years. Bar graphs represent mean ± standard error of the mean](https://figures.cochat.ai/paper-figures/9754e96052014b44bbc8490ae58d87f1/chronic-traumatic-encephalopathy-cte-criteria-for-neuropathological-diagnosis-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repetitive TBI is associated with chronic traumatic encephalopathy in young contact sport athletes (aged >18 years).36”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295
Self-citationThe spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098
Self-citationClinicopathological evaluation of chronic traumatic encephalopathy in players of American football
Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., Alosco, M. L., Solomon, T. M., Nowinski, C. J., McHale, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.8334 · Cited by 1,098
Self-citationGoldstein, L. E., Fisher, A. M., Tagge, C. A., Zhang, X.-L., Velisek, L., Sullivan, J. A., Upreti, C., Kracht, J. M., Ericsson, M., Wojnarowicz, M. W., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003716 · Cited by 958
Self-citationChronic Traumatic Encephalopathy in a National Football League Player
Omalu, B. I., DeKosky, S. T., Minster, R. L., Kamboh, M. I., Hamilton, R. L., & Wecht, C. H. (2005) · Neurosurgery · doi:10.1227/01.neu.0000163407.92769.ed · Cited by 894
the TBI/CTE group, McKee, A. C., Cairns, N. J., Dickson, D. W., Folkerth, R. D., Dirk Keene, C., Litvan, I., Perl, D. P., Stein, T. D., Vonsattel, J.-P., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1515-z · Cited by 885
Self-citationStructure-based classification of tauopathies
Shi, Y., Zhang, W., Yang, Y., Murzin, A. G., Falcon, B., Kotecha, A., van Beers, M., Tarutani, A., Kametani, F., Garringer, H. J., et al. (2021) · Nature · doi:10.1038/s41586-021-03911-7 · Cited by 878 · cited 1×
“used cryo-electron microscopy (EM) of p-tau filaments from three subjects with pathologically verified CTE, two boxers and a football player, to show that CTE tau fibrils have a unique molecular configuration consisting of an ordered core of two identical C-shaped protofilaments with a hydrophobic cavity enclosing an…”
MethodCorsellis, J. A. N., Bruton, C. J., & Freeman-Browne, D. (1973) · Psychological Medicine · doi:10.1017/s0033291700049588 · Cited by 836
MARTLAND, H. S. (1928) · Journal of the American Medical Association · doi:10.1001/jama.1928.02700150029009 · Cited by 774
Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules
Falcon, B., Zivanov, J., Zhang, W., Murzin, A. G., Garringer, H. J., Vidal, R., Crowther, R. A., Newell, K. L., Ghetti, B., Goedert, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1026-5 · Cited by 721
Research works printed but not linked: 3
- Farrell K, Cherry J, Bieniek K, Dickson D, White Iii C, Walker J et al (2020) Regional vulnerability to tau pathology in hippocampus differentiates chronic traumatic encephalopathy from primary age-related tauopathy. Oxford Univ Press Inc Journals Dept, 2001 Evans Rd, Cary, NC 27513 USA, City, pp 701–701
- Martland H (1928) Exhibit: types of traumatic cerebral hemorrhages. Hemorrhages due to concussion and their relationship to post-traumatic psychoses, and the condition known as “punch-drunk.” N Y Pathol Soc Trans Arch Pathol 6:542–544
- Millspaugh JA (1937) Dementia pugilistica. US Naval Med Bull 35:e303
Cited by
McKee, A. C., Mez, J., Abdolmohammadi, B., Butler, M. L. M. D., Huber, B. R., Uretsky, M., Babcock, K. J., Cherry, J. D., Alvarez, V. E., Martin, B. M., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.2907 · Cited by 190
Self-citationTau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Zhang, X., Wang, J., Zhang, Z., & Ye, K. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00429-6 · Cited by 125
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
White matter damage and degeneration in traumatic brain injury
Armstrong, R. C., Sullivan, G. M., Perl, D. P., Rosarda, J. D., & Radomski, K. L. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.07.003 · Cited by 79
Bielefeld, P., Martirosyan, A., Martín‐Suárez, S., Apresyan, A., Meerhoff, G. F., Pestana, F., Poovathingal, S. K., Reijner, N., Koning, W., Clement, R. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49299-6 · Cited by 71
Metadata
- Authors
- McKee, A. C., Stein, T. D., Huber, B. R., Crary, J. F., Bieniek, K., Dickson, D., Alvarez, V. E., Cherry, J. D., Farrell, K., Butler, M., Uretsky, M., Abdolmohammadi, B., Alosco, M. L., Tripodis, Y., Mez, J., & Daneshvar, D. H.
- Affiliations
- Boston University (US)
- Icahn School of Medicine at Mount Sinai (US)
- The University of Texas at San Antonio Health Science Center (US)
- Mayo Clinic in Florida (US)
- Corresponding author
- McKee, Ann C.
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2023-02-10
- Volume
- 145
- Issue
- 4
- Pages
- 371-394
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC10020327
- OpenAlex
- W4319826979
- Cited by
- 244
- References
- 118
- Citations by year
- 2026: 70 · 2025: 82 · 2024: 72 · 2023: 20
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (U54NS115266, U01 NS 086659, R01NS119651)
- National Institute of Aging (P30AG13846, U19AG06875, R01AG062348, RF1AG057902, K01AG070326)
- U.S. Department of Veterans Affairs (101BX002466, 101BX004613, BX004349)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Physical Sciences › Engineering › Biomedical Engineering › Automotive and Human Injury Biomechanics
- Keywords
- chronic traumatic encephalopathy, neuropathological diagnosis, phosphorylated tau, repetitive head impacts, contact athletes, traumatic encephalopathy syndrome, concussion, dose-response relationship, selection bias, finite element analysis
- MeSH terms
- Chronic Traumatic Encephalopathy, Animals, Australia, Brain, Canada, Cattle, Football, Humans, Male, tau Proteins, Tauopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts. https://app.cochat.ai/papers/10.1007/s00401-023-02540-w
- The paper
- McKee, A. C., Stein, T. D., Huber, B. R., Crary, J. F., Bieniek, K., Dickson, D., Alvarez, V. E., Cherry, J. D., Farrell, K., Butler, M., Uretsky, M., Abdolmohammadi, B., Alosco, M. L., Tripodis, Y., Mez, J., & Daneshvar, D. H. (2023). Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts. Acta Neuropathologica. https://doi.org/10.1007/s00401-023-02540-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.